Browsed by
Category: Success Stories

Unleashed Technologies Continues Growth and Adds 13 New Team Members In 2018

Unleashed Technologies Continues Growth and Adds 13 New Team Members In 2018

Fina Biosolutions and PATH Contract for Manufacturing Development and Scale-up of EcoCRM

Fina Biosolutions and PATH Contract for Manufacturing Development and Scale-up of EcoCRM

Fina Biosolutions LLC announced today it has reached agreement with PATH, a global organization focused on solving some of the world’s most pressing health challenges, under which PATH will provide funding and technical support for the clinical manufacture of FinaBio’s CRM197, known commercially as EcoCRM®. As consideration for this support, FinaBio has licensed PATH its CRM197, a key component in conjugate vaccines. Under the license, PATH receives non-exclusive rights to EcoCRM® for infectious disease vaccines sold to, or for supply to, low-income countries. ...  Read more

Maryland HIMSS Chapter ANNOUNCES ANNUAL HEALTH IT SCHOLARSHIP PROGRAM

Maryland HIMSS Chapter ANNOUNCES ANNUAL HEALTH IT SCHOLARSHIP PROGRAM

Baltimore, Maryland (June, 2018)- The Maryland HIMSS Chapter is pleased to announce the opening of their annual call for applications of their Health IT scholarships. Every year, Maryland HIMSS awards two deserving students actively enrolled in a health care information technology and/or computer science related degree program. ...  Read more

Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics

Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics

GAITHERSBURG, MD, June 6, 2018— Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in development of RNAi therapeutics, announces today that it has closed Series C1 financing of US$25 Million (RMB160 Million). This round of financing was led by Yuexiu New Industrial Investment, followed by Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment. The proceeds will be used to expand the clinical programs of the lead anti-fibrosis and anti-cancer RNAi therapeutics, strengthen the management team to support growth ...  Read more

GRSi Receives CEO Report’s 2018 Velocity Growth Award

GRSi Receives CEO Report’s 2018 Velocity Growth Award

GRSi has been named a winner of the 2018 Velocity Growth Award from CEO Report, their most prestigious award honoring the region’s fastest growing companies for their “determination, dedication and drive [putting] their organizations on the path to continued success that will impact the regional economic landscape for years to come and serve as an example to others.” GRSi President and CEO David Affeldt will accept the award on behalf of the organization at a gala to be held April 19 in Baltimore. ...  Read more

Jim Coleman, Prince George’s Co. Economic Development Corp.: ‘Poised for Growth’

Jim Coleman, Prince George’s Co. Economic Development Corp.: ‘Poised for Growth’

If you think the “E” in CEO only stands for “Executive,” you haven’t met Jim Coleman.
As President and Chief Executive Officer — or “Chief Excitement Officer,” as he calls himself — of the Prince George’s County Economic Development Corporation (EDC), the evanescent Coleman serves as the ring-leader of a movement to help attract, retain, and expand businesses in the county. ...  Read more

Unleashed Technologies Ranked #1 By Clutch.co

Unleashed Technologies Ranked #1 By Clutch.co

Clutch.co, an independent research firm based in the nation’s capital, recently announced its selections for 2017 Top Web Design Firms in Baltimore and 2017 Top Web Development Firms in Baltimore/DC and Unleashed Technologies is proud to have been recognized as the number one rated firm in both categories. Clutch’s research methodology takes into account new industry data and verified client feedback to rank the leading companies in these cities. ...  Read more